Organ Retractor Device Study

NCT06754514 · tracked via the Priya Life Science USA tracker

Sponsor

Boehringer Labs LLC

Phase

Observational

Started

2024-03-14

Last updated

2025-01-01

Condition(s) studied

Liver Retraction During Bariatric Surgery

Investigational drug(s) / intervention(s)

liver retraction

liver retraction: A different way to lift the liver during bariatric surgery

Study summary

This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * undergoing minimally invasive primary bariatric surgery Exclusion Criteria: * known liver disease

Primary outcome measure(s)

Ease of use and Feasibility — During surgery
After surgery, surgeons will be asked a series of questions and asked to rank the ease of use on a scale of 1-10

Trial sites (1)

Facility	City	Region	Status
WakeMed Health & Hospitals	Raleigh	North Carolina	Recruiting

More Boehringer Labs LLC trials in the USA

Large Diameter ViSiGi LUX ™ Gastric Sizing and Calibration System Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06754514 on ClinicalTrials.gov ↗ ← All trials in the USA